Stocks · Health care · Pharmaceutical Preparations

ALUMIS INC.

ALMS Clue Score37
United States Fiscal year ends December CIK 0001847367 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Srinivas Akkaraju
8 Sep 2026
Director
Buy indirect
273,290
$10.63
$2.90M
Srinivas Akkaraju
8 Sep 2026
Director
Buy indirect
273,291
$10.63
$2.90M
Srinivas Akkaraju
4 Sep 2026
Director
Buy indirect
220,070
$11.17
$2.46M
Srinivas Akkaraju
4 Sep 2026
Director
Buy indirect
220,070
$11.17
$2.46M
Srinivas Akkaraju
9 Jan 2026
Director
Buy indirect
588,235
$17.00
$10.00M
James B. Tananbaum
8 Jan 2026
Director
Buy indirect
294,117
$17.00
$5.00M
James B. Tananbaum
8 Jan 2026
Director
Buy indirect
117,647
$17.00
$2.00M
Foresite Capital Management VI LLC
8 Jan 2026
10% owner
Buy indirect
294,117
$17.00
$5.00M
Foresite Capital Management VI LLC
8 Jan 2026
10% owner
Buy indirect
117,647
$17.00
$2.00M
Foresite Labs, LLC
8 Jan 2026
10% owner
Buy indirect
294,117
$17.00
$5.00M
Foresite Labs, LLC
8 Jan 2026
10% owner
Buy indirect
117,647
$17.00
$2.00M
Srinivas Akkaraju
5 Dec 2025
Director
Buy indirect
51,380
$10.73
$551.31K
Srinivas Akkaraju
5 Dec 2025
Director
Buy indirect
70,028
$10.01
$700.98K
Srinivas Akkaraju
5 Dec 2025
Director
Buy indirect
64,969
$8.95
$581.47K
Srinivas Akkaraju
4 Dec 2025
Director
Buy indirect
66,027
$8.18
$540.10K
Srinivas Akkaraju
3 Dec 2025
Director
Buy indirect
100,000
$7.75
$775.00K
Srinivas Akkaraju
2 Dec 2025
Director
Buy indirect
96,000
$7.55
$724.80K
Srinivas Akkaraju
1 Dec 2025
Director
Buy indirect
86,350
$7.46
$644.17K
Srinivas Akkaraju
28 Nov 2025
Director
Buy indirect
38,702
$7.64
$295.68K
Srinivas Akkaraju
26 Nov 2025
Director
Buy indirect
48,537
$7.64
$370.82K
Foresite Labs, LLC
21 Nov 2025
10% owner
Buy indirect
72,212
$7.38
$532.92K
James B. Tananbaum
21 Nov 2025
Director
Buy indirect
72,212
$7.38
$532.92K
Foresite Capital Management VI LLC
21 Nov 2025
10% owner
Buy indirect
72,212
$7.38
$532.92K
Srinivas Akkaraju
20 Nov 2025
Director
Buy indirect
125,743
$7.20
$905.35K
Srinivas Akkaraju
19 Nov 2025
Director
Buy indirect
137,772
$6.56
$903.78K
James B. Tananbaum
19 Nov 2025
Director
Buy indirect
190,500
$6.56
$1.25M
Foresite Capital Management VI LLC
19 Nov 2025
10% owner
Buy indirect
190,500
$6.56
$1.25M
Foresite Labs, LLC
19 Nov 2025
10% owner
Buy indirect
190,500
$6.56
$1.25M
Srinivas Akkaraju
18 Nov 2025
Director
Buy indirect
102,652
$6.05
$621.04K
James B. Tananbaum
18 Nov 2025
Director
Buy indirect
117,374
$6.19
$726.55K
Foresite Capital Management VI LLC
18 Nov 2025
10% owner
Buy indirect
117,374
$6.19
$726.55K
Foresite Labs, LLC
18 Nov 2025
10% owner
Buy indirect
117,374
$6.19
$726.55K
Srinivas Akkaraju
17 Nov 2025
Director
Buy indirect
914
$5.51
$5.04K
James B. Tananbaum
17 Nov 2025
Director
Buy indirect
150,000
$5.59
$838.50K
James B. Tananbaum
17 Nov 2025
Director
Buy indirect
50,000
$5.60
$280.00K
Foresite Capital Management VI LLC
17 Nov 2025
10% owner
Buy indirect
150,000
$5.59
$838.50K
Foresite Capital Management VI LLC
17 Nov 2025
10% owner
Buy indirect
50,000
$5.60
$280.00K
Foresite Labs, LLC
17 Nov 2025
10% owner
Buy indirect
150,000
$5.59
$838.50K
Foresite Labs, LLC
17 Nov 2025
10% owner
Buy indirect
50,000
$5.60
$280.00K
Srinivas Akkaraju
13 Nov 2025
Director
Buy indirect
276,179
$5.25
$1.45M

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 12,360,507
History held since 1 Jul 2024